AMETEK, Inc. (AME)

FairStock Score: 51/100 — MIXED

Key Financials

Strengths

• Exceptional operating margins (19.95% net margin) with proven pricing power in specialized markets
• Strong free cash flow generation ($1.3B annually) and conservative balance sheet (D/E 0.24) enabling strategic M&A and shareholder returns
• Diversified end markets (aerospace, semiconductor, pharma, oil & gas) reducing cyclical exposure and providing multiple growth vectors
• Demonstrated competitive moats through specialized instrumentation and customer switching costs in mission-critical applications
• Solid Piotroski F-Score (7/9) and Altman Z-Score (6.95) indicating financial stability and quality earnings

Concerns

• Valuation disconnected from fundamentals: P/E of 32.66 and EV/EBITDA of 87.94 leave virtually no margin of safety; Graham Number suggests 82% downside to intrinsic value
• Suboptimal ROCE of 7.88% relative to cost of capital, questioning capital deployment efficiency despite strong ROE
• Limited growth visibility: FCF yield of 1.0% implies market expects perpetual high-single-digit growth at best, leaving no cushion for deceleration
• FairStock Score of 44/100 reflects fundamental overvaluation relative to quality, signaling elevated execution risk

AI Analysis

AMETEK presents a classic case of quality at an unreasonable price. The business itself is excellent—a diversified industrial manufacturer with sticky, high-margin products serving aerospace, semiconductor, and process automation markets. The latest quarter demonstrates impressive operational leverage with 19.95% net margins and $1.3B in free cash flow generation. This is a compounder with genuine competitive moats through specialized instrumentation and customer lock-in. However, I must be candid: at $221.98, the valuation is simply indefensible by Graham principles. The Graham Number of $42.63 reveals a margin of safety of -420%, meaning the stock would need to fall 82% to reach intrinsic value by conservative metrics. The P/E of 32.66 paired with an EV/EBITDA of 87.94 suggests the market has priced in perpetual growth at exceptional rates. While ROCE of 7.88% is concerning relative to capital deployed, the 14.59% ROE and fortress balance sheet (D/E of 0.24) indicate financial strength. The Piotroski F-Score of 7/9 shows solid operational fundamentals, and the Altman Z-Score of 6.95 confirms solvency. Yet I cannot recommend purchasing at current levels. This is a business I'd love to own at $120-140, but at double that, the risk-reward is inverted. Growth trajectory appears intact, but valuation leaves no room for disappointment.

Bull Case

AMETEK's market-leading position in high-growth verticals like semiconductor instrumentation and aerospace electromechanicals could justify premium multiples if the company sustains double-digit growth and continues expanding margins through operational excellence. Inorganic growth via acquisitions could unlock synergies and accelerate cash generation, supporting the current valuation.

Bear Case

Economic slowdown in aerospace or semiconductors could trigger meaningful margin compression and growth deceleration, exposing the stock's extreme valuation. At 32x earnings with declining ROCE, any disappointment could cascade into a 30-40% correction as multiple compression compounds earnings weakness.

Data from SEC filings. AI analysis is for educational purposes only — not investment advice. Scoring methodology · Disclaimer